Urogen Pharma (URGN)
(Real Time Quote from BATS)
$15.22 USD
-0.46 (-2.93%)
Updated Aug 5, 2024 12:32 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.82 |
EPS Last Quarter | -0.97 |
Last EPS Surprise | -4.30% |
ABR | 1.40 |
Earnings ESP
|
2.83% |
---|---|
Current Year | -3.41 |
Next Year | -2.44 |
EPS (TTM) | -3.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 23.69M | 24.47M | 95.78M | 148.44M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 24.87M | 25.00M | 97.00M | 166.30M |
Low Estimate | 22.50M | 23.93M | 94.55M | 130.58M |
Year ago Sales | 21.14M | 20.85M | 82.71M | 95.78M |
Year over Year Growth Est. | 12.04% | 17.34% | 15.79% | 54.99% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.82 | -0.82 | -3.41 | -2.44 |
# of Estimates | 3 | 2 | 4 | 4 |
Most Recent Consensus | -0.77 | -0.75 | -3.16 | -2.72 |
High Estimate | -0.77 | -0.75 | -3.16 | -1.61 |
Low Estimate | -0.90 | -0.88 | -3.60 | -3.13 |
Year ago EPS | -1.03 | -0.68 | -3.55 | -3.41 |
Year over Year Growth Est. | 20.39% | -20.59% | 3.94% | 28.37% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 2 | 1 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.82 | -0.82 | -3.41 | -2.44 |
7 Days Ago | -0.82 | -0.82 | -3.41 | -2.44 |
30 Days Ago | -0.84 | -0.82 | -3.52 | -2.52 |
60 Days Ago | -0.88 | -0.87 | -3.60 | -2.94 |
90 Days Ago | -0.89 | -0.90 | -3.59 | -1.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.80 | -0.82 | -3.45 | -2.30 |
Zacks Consensus Estimate | -0.82 | -0.82 | -3.41 | -2.44 |
Earnings ESP | 2.83% | 0.00% | -1.25% | 5.74% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.97 | -0.72 | -0.68 | -1.03 | NA |
Estimate | -0.93 | -0.67 | -0.89 | -1.13 | NA |
Difference | -0.04 | -0.05 | 0.21 | 0.10 | 0.06 |
Surprise | -4.30% | -7.46% | 23.60% | 8.85% | 5.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more